Industry Developments

BMI View: Unlike other countries in the Middle East that have focused on encouraging pharmaceutical companies to establish manufacturing facilities, Qatar's focus is on education and... 2012-05-11

BMI View: While Teva's Q112 results were not terrible compared to Q411, as revenues and profits both saw reasonable growth, and considering the recent acquisitions of Cephalon and Taiyo,... 2012-05-10

BMI View: It is in the interest of local and multinational drugmakers to assist African markets in the field of pharmacovigilance (PV). Unfortunately, while PV systems are important... 2012-05-09

BMI View: Increased investment in private healthcare infrastructure across the Gulf Cooperation Council (GCC) region will increase standards of care, making it a more appealing destination... 2012-05-08

BMI View: The Zimbabwean government's latest industrial policy emphasises the need to support the local industry in a small number of specific areas to help promote the country's export... 2012-05-03

BMI View: Despite the upcoming expiry of the US patent for Plavix (clopidogrel), BMI believes Bristol-Myers Squibb (BMS) remains in a strong position, primarily due to the success it... 2012-05-02

BMI View: Bayer's Q112 results show the company's profitability is up as there are fewer special items incurring costs than a year earlier. In addition, the company's sales are driven... 2012-05-01

BMI View: Israel will continue to attract investment because of a strong culture of entrepreneurism that has led to a large number of life science start-up companies. In particular,... 2012-04-27

BMI View: With the push into emerging markets by pharmaceutical companies and the dangers of importing drugs into the Algerian market well documented, it makes sense that large multinational... 2012-04-25

BMI View: Aspen Pharmacare's increased cooperation in the marketing and production of GlaxoSmithKline (GSK)'s drugs is completely in line with BMI's views about the partnership between... 2012-04-24